UBS’s Silver Standard Resources SSRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$49K Buy
8,100
+2,000
+33% +$17.1K ﹤0.01% 6871
2014
Q2
$53K Sell
6,100
-1,200
-16% -$10.4K ﹤0.01% 6792
2014
Q1
$72K Sell
7,300
-4,000
-35% -$37.6K ﹤0.01% 6392
2013
Q4
$79K Sell
11,300
-27,300
-71% -$165K ﹤0.01% 6373
2013
Q3
$237K Buy
38,600
+3,600
+10% +$27K ﹤0.01% 4977
2013
Q2
$222K Buy
+35,000
New +$258K ﹤0.01% 4988

Other funds holding SSRI

UBS's SSRI Position: Q3 2014 in Review

UBS reduced its Silver Standard Resources (SSRI) stake by 25% in Q3 2014, selling an estimated $488K and leaving 172,074 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #3543.

UBS first reported a position in SSRI in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.99M in Q2 2014. 98 funds tracked by Wall St. Rank hold SSRI as of Q3 2014.

  • UBS held 172,074 shares of Silver Standard Resources worth $1.05M as of Q3 2014.
  • UBS sold 57,229 Silver Standard Resources shares in Q3 2014, an estimated $488K.
  • Silver Standard Resources made up ﹤0.01% of UBS's portfolio in Q3 2014, its #3543 holding.
  • UBS first reported a position in Silver Standard Resources in Q2 2013 and has held it in 6 quarters since.
  • UBS's Silver Standard Resources position peaked at $1.99M in Q2 2014.
  • 98 funds tracked by Wall St. Rank held Silver Standard Resources as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.